Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Medicines Co.

Start price
Target price
Perf. (%)
€24.58
18.02.15
€28.00
07.09.15
45.81%
07.09.15

buy
Celgene Corp.

Start price
Target price
Perf. (%)
€110.27
10.04.15
€150.00
27.07.15
7.47%
27.07.15

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€65.85
05.05.15
€83.00
22.07.15
19.78%
22.07.15

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€61.31
11.03.15
€67.00
22.07.15
3.33%
22.07.15

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Top 10 in its market
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€87.59
30.06.15
€95.00
16.07.15
6.07%
16.07.15

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€112.31
17.04.15
€125.00
16.07.15
0.72%
16.07.15

buy
Zimmer Holdings

Start price
Target price
Perf. (%)
€106.84
03.03.15
€120.00
07.07.15
-8.84%
07.07.15

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€93.74
04.05.15
€110.00
29.06.15
11.35%
29.06.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Mateon Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.45
01.12.14
€1.75
01.06.15
-10.37%
01.06.15

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€56.90
30.01.15
€65.00
14.04.15
1.83%
14.04.15

buy
Pharmacyclics

Start price
Target price
Perf. (%)
€130.29
22.01.15
€142.00
10.04.15
83.46%
10.04.15

buy
Endocyte Inc.

Start price
Target price
Perf. (%)
€4.62
07.10.14
€8.30
07.04.15
18.81%
07.04.15

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.55
01.10.14
€2.00
01.04.15
110.38%
01.04.15

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€87.67
09.12.14
€99.00
25.03.15
6.68%
25.03.15

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€52.50
27.04.14
€120.00
23.03.15
67.05%
23.03.15

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€53.53
22.01.15
€84.00
20.03.15
1.23%
20.03.15

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€85.69
05.02.15
€100.00
18.03.15
7.04%
18.03.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Rockwell Medical Inc.

Start price
Target price
Perf. (%)
€101.04
03.02.15
€132.00
12.03.15
2.66%
12.03.15

buy
Momenta Pharmaceuticals

Start price
Target price
Perf. (%)
€9.34
09.02.15
€10.30
13.02.15
8.64%
13.02.15

buy
Epirus Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€4.29
08.02.15
€5.70
13.02.15
43.03%
13.02.15

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€81.88
08.09.14
€95.00
28.01.15
12.25%
28.01.15

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Zimmer Holdings

Start price
Target price
Perf. (%)
€93.72
08.12.14
€110.00
27.01.15
7.28%
27.01.15

buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€114.22
03.12.14
€130.00
26.01.15
10.80%
26.01.15

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€86.15
28.11.14
€92.00
23.01.15
6.79%
23.01.15

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.90
27.10.14
€25.62
12.12.14
11.39%
12.12.14

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies